BRAND NEW VIDEO UPLOADED DAILY; Explosive Stocks Just Starting To Move Out Of Sideway Boring Action; TIMING IS EVERY THING... Our goal is for you to make money from day one of your purchase.
This is a list of stocks that look ready to take off at any time... Place stops below the recommended buy price... This information should not be used without first consulting your investment agent and or broker...
Today the featured stocks are;
Sinovac Biotech Ltd. (SVA)
LanOptics Ltd. (LNOP)
Industry: Networking & Communication Devices
LNOP, SVA, stock technical analysis, japanese candlesticks, ACPW, AETI, AUSA, BIDZ, CIZN, CLDA, CNVR, COMS, INVC, LMAT, MBND, MMPI, MODT, NGA, ONCY, QUIP, SSTR, SUFB, SYNL, TMNG, TRNS, TZOO, WHRT, XTLB, ZVUE, AAB-WT, AE, ANV, APT, AZK, BAA, BCP, BYW-WT, CDY, CNU, DPW, ECI, EPM, FHC, FRH-WT, FXX, GTF, HBE, HH, LMZ, MDM, NEP, PXG, THM, WEL, ACN, ANW, BMN, CBK, CRY, ENT, EPC, FA, FMT-P, FRE-PL, FRE-PN, G, GG-WT, IIT, IQW, LUM, MIC, NTZ, TGS, TGX, TWP, WCC, WLM, WNI, WNS,
Good Friday Morning, Its August 12th, 2011, I’m Sara Bryant with CRWENewswire Stocks In Action. The board of directors of Midas Incorporated - symbol MDS - are Reviewing Strategic and financial alternatives for the company which may include, but are not limited to, a possible sale, merger or other business combination. According to its Unaudited Second Quarter 2011 Financial Results, the Sales of Sinovac Biotech limited - symbol SVA - increased 52.5% year-over-year to $15.7 million. Sinovac has obtained the GMP certificate for its seasonal flu vaccine and hepatitis A vaccine from the Federal Commission for the Protection Against Sanitary Risk of Mexico Ministry of Health. MannKind Corporation - symbol MNKD - has confirmed with the U.S. Food and Drug Administration the design of two clinical studies that evaluate the efficacy and safety of AFREZZA. AFREZZA is a novel, ultra rapid acting mealtime insulin therapy being developed by MannKind Corporation for the treatment of adult patients with type 1 or type 2 diabetes for the control of hyperglycemia (high blood glucose). Thanks for joining me and have a great weekend! For CRWE Newswire, Stocks In Action, I’m Sara Bryant
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire**** publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at *******www.crwenewswire****/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold crwenewswire**** report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
Good Morning, Its Wednesday November 9th, 2011, I’m Christina Collins with CRWENewswire Stocks In Action. On its third quarter fiscal 2011, KIT digital Incorporated - symbol KITD - posted record Revenue of $62.3 million, an increase of 29% sequentially and 124% year over year. Supreme Industries Incorporated - symbol STS - reported that its Consolidated net sales increased 19% to $72.8 million in the third quarter fiscal 2011, compared to the same period the prior year. and lastly; Sinovac Biotech Limited - symbol SVA - reported positive top-line results from its phase II clinical trial for its proprietary inactivated vaccine against human enterovirus 71 or EV71, which causes hand, foot and mouth disease (HFMD), a contagious viral illness that commonly affects infants and children. Thanks for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Christina Collins